Abstract:Background: The administration of neuropathic pain (NP) poses a major clinical challenge, since its complex mechanisms have not been fully elucidated. The aim of this study was to identify molecular changes associated with NP progression. Methods: NP-related differentially expressed genes (DEGs) in both dorsal root ganglion (DRG) and spinal cord (SC) were identified using microarray analysis based on chronic constriction injury (CCI) rat model. Then, a candidate signal axis involved into NP progression was screened by molecular interaction network analysis. Moreover, its roles in mechanical and thermal hyperalgesias of CCI rats, as well as in regulating downstream signaling were also determined in vivo. Findings: Among 92 DEGs in both DRG and SC between CCI and sham-operated rats, Clec7a was the only upregulated gene with fold change >4 after CCI insult, which were also verified by qPCR and Western blot. CCI modeling increased the number of GFAP/Clec7a and Iba-1/Clec7a positive astrocytes and microglias in both DRG and SC. In contrast, the intrathecal injection of Clec7a siRNA significantly increased the mechanical and thermal hyperalgesia of CCI rats. Mechanically, network and pathway analyses showed the involvement of Clec7a in Toll-like signaling pathway and its functional interaction with Toll-Like Receptor 4 (TLR4). Further experimental validation demonstrated that the knockdown of Clec7a markedly inhibited the expression of TLR4 and, consequently, reduced the release of pro-inflammatory cytokines including TNFα, IL-1β, and IL-6. Interpretation: Clec7a may be a potential target to relieve NP via inhibiting neuroinflammation activation through regulating TLR4 expression, suggesting a promising approach for NP therapy. Funding Statement: The funding sources of this study are from National Natural Science Foundation of China, the National Key Technology R & D Program of China, and National Key Research and Development Program of China. No study sponsors are involved in the research process of this project.Declaration of Interests: The authors declare that there is no conflict of interests regarding the publication of this paper.Ethics Approval Statement: All experimental protocols and animal-handling procedures were approved by our institutional Animal Care Committee and were performed in accordance with the recommendations outlined in the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health.

Disruption of C/EBPβ-Clec7a axis exacerbates neuroinflammatory injury via NLRP3 inflammasome-mediated pyroptosis in experimental neuropathic pain

The Involvement of Spinal Annexin A10/NF-κB/MMP-9 Pathway in the Development of Neuropathic Pain in Rats

Pi3k Contributed To Modulation Of Spinal Nociceptive Information Related To Ephrinbs/Ephbs

Clec7a is a Potential Target to Relieve Neuropathic Pain Via Inhibiting Neuroinflammation Activation Through Regulating TLR4 Expression

Cx3cl1/Cx3cr1 Regulates Nerve Injury-Induced Pain Hypersensitivity Through The Erk5 Signaling Pathway

Inhibition of Schwann Cell Pannexin 1 Attenuates Neuropathic Pain Through the Suppression of Inflammatory Responses

NF-κB p65-dependent transcriptional regulation of histone deacetylase 2 contributes to the chronic constriction injury-induced neuropathic pain via the microRNA-183/TXNIP/NLRP3 axis

Temporal Changes of Spinal Transcriptomic Profiles in Mice With Spinal Nerve Ligation.

C/EBPβ Participates in Nerve Trauma-Induced TLR7 Upregulation in Primary Sensory Neurons

Research progress of targeting NLRP3 inflammasome in peripheral nerve injury and pain

Elevated plasma CXCL12 leads to pain chronicity via positive feedback upregulation of CXCL12/CXCR4 axis in pain synapses

P2X7 Receptor of Microglia Mediates Neuropathic pain by Regulating Autophagy After Chronic-Constriction Injury

CCR1 enhances SUMOylation of DGCR8 by up-regulating ERK phosphorylation to promote spinal nerve ligation-induced neuropathic pain

Astrocyte-microglia interaction through C3/C3aR pathway modulates neuropathic pain in rats model of chronic constriction injury

CXCL13 contributes to chronic pain of a mouse model of CRPS-I via CXCR5-mediated NF-κB activation and pro-inflammatory cytokine production in spinal cord dorsal horn

ZNF382 controls mouse neuropathic pain via silencer-based epigenetic inhibition of Cxcl13 in DRG neurons

Astrocytic connexin 43 deletion ameliorates SNI-induced neuropathic pain by reducing microglia activation

Involvement of the spinal NALP1 inflammasome in neuropathic pain and aspirin-triggered-15-epi-lipoxin A4 induced analgesia.

CNTF-STAT3-IL-6 Axis Mediates Neuroinflammatory Cascade Across Schwann Cell-Neuron-Microglia.

LncRNA-PCat19 acts as a ceRNA of miR-378a-3p to facilitate microglia activation and accelerate chronic neuropathic pain in rats by promoting KDM3A-mediated BDNF demethylation

miR-223 Inhibits the Polarization and Recruitment of Macrophages via NLRP3/IL-1 β Pathway to Meliorate Neuropathic Pain